E-cadherin gene 3′-UTR C/T polymorphism is associated with prostate cancer

Urologia Internationalis

Volumn 75, Issue 4, 2005, Pages 350-353

  Wu, Hsi Chin ^a   Lai, Ming Tsung ^b   Wu, Chao I ^a   Chen, Huey Yi ^a   Wan, Lei ^a   Tsai, Fuu Jen ^a   Chen, Wen Chi ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

CDH 1; E cadherin; Prostate cancer

Indexed keywords

ANTIANDROGEN; UVOMORULIN;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ANAMNESIS; ARTICLE; CANCER HORMONE THERAPY; CANCER PATIENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION MAPPING; UROLITHIASIS;

AGED; AGED, 80 AND OVER; ALLELES; BIOPSY, NEEDLE; CADHERINS; DISEASE PROGRESSION; DNA, NEOPLASM; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 28644439527     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089173     Document Type: Article

References (20)

1. Okegawa T, Pong RC, Li Y, Hsieh JT: The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol 2004;51:445-457.
2. Birchmeier W, Behrens J: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994;1198:11-26.
3. Aberle H, Schwartz H, Kemler R: Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem 1996;61:514-523.
4. Hsu YS, Wang JS, Wu TT: E-cadherin expression in prostate adenocarcinomas in Chinese and its pathological correlates. Urol Int 2004;73:36-40.
5. Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M, et al: Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 1989;49:2128-2133.
6. Krill D, Thomas A, Wu SP, Dhir R, Becich MJ: E-cadherin expression and PSA secretion in human prostate epithelial cells. Urol Res 2001;29:287-292.
7. Gumbiner BM: Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-357.
8. Becker KF, Reich U, Schott C, Hofler H: Single nucleotide polymorphisms in the human E-cadherin gene. Hum Genet 1995;96:739-740.
9. Tsai FJ, Wu HC, Chen HY, Lu HF, Hsu CD, Chen WC: Association of E-cadherin gene 3′-UTR C/T polymorphism with calcium oxalate stone disease. Urol Int 2003;70:278-281.
10. Lee YH, Huang WC, Tsai JY, Lu CM, Chen WC, Lee MH, et al: Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int 2002;68:172-177.
11. Kuefer R, Hofer MD, Gschwend JE, Pienta KJ, Sanda MG, Chinnaiyan AM, et al: The role of an 80-kDa fragment of E-cadherin in the metastatic progression of prostate cancer. Clin Cancer Res 2003;9:6447-6452.
12. Chunthapong J, Seftor EA, Khalkhali-Ellis Z, Seftor RE, Amir S, Lubaroff DM, et al: Dual roles of E-cadherin in prostate cancer invasion. J Cell Biochem 2004;91:649-661.
13. Gsur A, Feik E, Madersbacher S: Genetic polymorphisms and prostate cancer risk. World J Urol 2004;21:414-423.
14. Jonsson BA, Adami HO, Hagglund M, Bergh A, Goransson I, Stattin P, et al: -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer. Int J Cancer 2004;109:348-352.
15. Verhage BA, van Houwelingen K, Ruijter TE, Kiemeney LA, Schalken JA: Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer. Int J Cancer 2002;100:683-685.
16. Tsukino H, Kuroda Y, Imai H, Nakao H, Qiu D, Komiya Y, et al: Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer. Urol Int 2004;72:203-207.
17. Gsur A, Preyer M, Haidinger G, Zidek T, Madersbacher S, Schatzl G, et al: Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk. Carcinogenesis 2002;23:1647-1651.
18. Irvine RA, Yu MC, Ross RK, Coetzee GA: The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 1995;55:1937-1940.
19. Xue W, Irvine RA, Yu MC, Ross RK, Coetzee GA, Ingles SA: Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res 2000;60:839-841.
20. Lunn RM, Bell DA, Mohler JL, Taylor JA: Prostate cancer risk and polymorphism in 17-hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenesis 1999;20:1727-1731.